35 results
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
) CannAmide™, a proprietary Palmitoylethanolamide, or PEA, formulation. PEA is an endogenous fatty acid amide that belongs to the class of nuclear factor
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
) CannAmide™, a proprietary Palmitoylethanolamide, or PEA, formulation. PEA is an endogenous fatty acid amide that belongs to the class of nuclear factor … of nuclear factor agonists, which are molecules that regulate the expression of genes. We believe that the combination of THC and PEA may induce
6-K
EX-99.1
SPRC
SciSparc Ltd
27 Nov 23
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
4:00pm
and Investment Agreement, signed on March 10, 2022 (the “Agreement”).
MitoCareX Bio is a drug discovery company focusing on targeting the nuclear encoded
6-K
EX-99.2
SPRC
SciSparc Ltd
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
, and (2) CannAmide™, a proprietary PEA formulation. PEA is an endogenous fatty acid amide that belongs to the class of nuclear factor agonists, which
6-K
EX-99.2
fi0 wasiz
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.2
shk5 rae7p4
16 Aug 21
Interim Consolidated Financial Statements
12:00am
424B4
1gmdxa3b7a t6ii
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1/A
7v7b93mw
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
hsmkyzxs033mg9c
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
EX-99.2
phegk41 kq632oth
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
25ucepvbe1o18
9 Oct 20
Registration statement (foreign) (amended)
12:00am
F-1
qhdlb gg6n8o60s
8 Sep 20
Registration statement (foreign)
5:31pm
424B4
sh2wpbc
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
dg5pgi
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
7wgsb vo7d7fvxld
30 Mar 20
Registration statement (foreign) (amended)
12:29pm